Rocket Pharmaceuticals Stock Forecast

Stock Price Forecast

The 13 analysts that cover Rocket Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $29.65, which forecasts a 502.64% increase in the stock price over the next year. The lowest target is $2.50 and the highest is $263.

Price Target: $29.65 (+502.64%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.50	$29.65	$8.00	$263
Change	-49.19%	+502.64%	+62.60%	+5245.5%

Analyst Ratings

The average analyst rating for Rocket Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	4	4	4	4	4	4
Buy	4	4	4	4	4	4
Hold	5	5	5	5	5	4
Sell	0	1	1	1	1	1
Strong Sell	0	0	0	0	0	1
Total	13	14	14	14	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Richard Law Goldman Sachs	Goldman Sachs	Strong Sell Maintains $2 → $3	Strong Sell	Maintains	$2 → $3	-39.02%	Mar 2, 2026
Josh Schimmer Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $8 → $10	Buy	Maintains	$8 → $10	+103.25%	Feb 27, 2026
Jason Zemansky B of A Securities	B of A Securities	Strong Buy Maintains $10 → $8	Strong Buy	Maintains	$10 → $8	+62.60%	Nov 18, 2025
Tessa Romero JP Morgan	JP Morgan	Buy → Sell Downgrades $261 → $263	Buy → Sell	Downgrades	$261 → $263	+5,245.53%	Nov 18, 2025
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $11	Strong Buy	Maintains	$11	+123.58%	Oct 14, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

18.37M

Revenue Next Year

36.31M

from 18.37M

97.68%

from 18.37M

EPS This Year

-1.55

from -2.01

EPS Next Year

-1.25

from -1.55

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	18.37M	36.31M
Revenue Growth	-	-	-	-	-	-	97.68%
EPS	-2.67	-3.26	-2.92	-2.73	-2.01	-1.55	-1.25
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	17	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	150.2M	136.5M
Avg	18.4M	36.3M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	643.1%
Avg	-	97.7%
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.06	-0.78
Avg	-1.55	-1.25
Low	-1.79	-1.97

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.